Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults.


B-cell depletion therapy can be effective for treating B-cell lymphomas as well as many human and murine autoimmune diseases. B-cell-deficient mice are normally resistant to spontaneous autoimmune thyroiditis (SAT), but they develop SAT if regulatory T cells are transiently depleted during the first 3-6 weeks after birth. This was also a critical time when… (More)
DOI: 10.1093/intimm/dxs003

10 Figures and Tables


  • Presentations referencing similar topics